Home/Publication/Adlai Nortye Debuts on Nasdaq
Adlai Nortye Debuts on Nasdaq 

04 Oct 2023

US$ 19.00

Adlai Nortye Ltd (Adlai), a cancer therapies developer backed by Matrix Partners China and Beijing Legend Star...

Price / article: US$19.00
OR existing subscriber
Tag
IPO
Related Publications

A consortium which consists of Abu Dhabi Investment Authority (ADIA), Global Infrastructure Partners, Khazanah Nasional...

KKR & Co Inc (KKR) announced its intention to launch its second tranche of tender offer (TOB) for shares of FUJI SOFT...

Connect With Us

We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.

Rest assured that your email address will not be shared, as we hate spams as much as you do.